Reducing Low-Density Lipoprotein Cholesterol After Myocardial Infarction in Older Individuals, Levels Versus Change: Can Observational Studies Answer the Questions?

about

Reducing Low-Density Lipoprotein Cholesterol After Myocardial Infarction in Older Individuals, Levels Versus Change: Can Observational Studies Answer the Questions?

Item

http://www.wikidata.org/entity/Q55422159

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Reducing Low-Density Lipoprote ...... Studies Answer the Questions?

@en

Reducing Low-Density Lipoprote ...... Studies Answer the Questions?

@nl

type

Item

label

Reducing Low-Density Lipoprote ...... Studies Answer the Questions?

@en

Reducing Low-Density Lipoprote ...... Studies Answer the Questions?

@nl

prefLabel

Reducing Low-Density Lipoprote ...... Studies Answer the Questions?

@en

Reducing Low-Density Lipoprote ...... Studies Answer the Questions?

@nl

P1476

Reducing Low-Density Lipoprote ...... Studies Answer the Questions?

@en

P2093

Lewis H Kuller

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular Disease Risk in Patients with Rheumatic Diseases.

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials.

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Exercise-induced myalgia may limit the cardiovascular benefits of statins.

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.

Long-term follow-up of lipid-lowering trials.

A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.

Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes.

Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.

P31

scholarly article

editorial

P356

10.1161/JAHA.118.009430

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29754126

http://www.w3.org/2001/XMLSchema#string

P921

lipoprotein

P932

6015323

http://www.w3.org/2001/XMLSchema#string